The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
MR Shafie Pour,1 T Sadeghiyeh,2 M Hadavi,3,4 M Besharati,5 R Bidaki61Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran;...
Guardado en:
Autores principales: | Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3482e4b07211459ebd9f284584131d49 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Seismic vulnerability of Yazd
por: Vahid Rashidinia, et al.
Publicado: (2016) -
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017) -
Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai S, et al.
Publicado: (2020) -
Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
por: Thomann R, et al.
Publicado: (2020) -
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz S
Publicado: (2010)